Clinical Trial Update: Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ipilimumab and nivolumab with thoracic radiotherapy for extensive-stage small cell lung cancer has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Small Cell Lung Cancer, Extensive-stage Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-10-11